Name
GS02-06 - Recurrence-free survival following sentinel node-positive breast cancer without completion axillary lymph node dissection – first results from the international randomized SENOMAC trial.
Date & Time
Thursday, December 7, 2023
Speakers
Virtual Session Link
OnDemand Video URL